DEMOCRATIC REPUBLIC OF THE CONGO / RankWire.AI / – The Congo’s Ministry of Public Health reports that by August 3, the country’s Ebola outbreak had reached 3,874 confirmed infections and caused 1,751 fatalities, marking the largest epidemic ever recorded in Congo. Globally, it ranks as the second-worst outbreak after the 2014 to 2016 West Africa epidemic. Congo hit 1,000 confirmed cases within just 40 days after initiating its response efforts. In contrast, Congo’s 2018 outbreak took approximately 235 days to reach the same milestone. The rapid escalation highlights challenges such as delayed detection, weak surveillance, ongoing conflict, population mobility, and the lack of approved strain-specific medical interventions.
Congo’s Ministry of Public Health announced the outbreak on May 15 after testing identified Bundibugyo virus in Ituri province. WHO initially received a warning on May 5, following reports of a lethal, unidentified illness near Mongbwalu. Further investigations revealed that the virus had been circulating unnoticed for months before authorities identified the outbreak. Early tests in Bunia failed to detect Bundibugyo, as initial symptoms resembled malaria and other common febrile illnesses. This delay in recognition allowed infected individuals and contacts to travel through communities before isolation and contact tracing could be effectively implemented.
The emergence of the Bundibugyo species has also altered the available response strategies. Vaccines and antibody treatments approved for Zaire ebolavirus, which caused Congo’s 2018 to 2020 epidemic, are ineffective against Bundibugyo virus disease. Consequently, patient management now relies on early diagnosis, isolation, supportive care, infection prevention, contact tracing, and safe burial practices. Although the WHO has added a Bundibugyo diagnostic test to its emergency list and begun treatment research, these measures were initiated only after the virus had already spread extensively.
Delayed Detection Hampers Contact Tracing Efforts
The outbreak has expanded from Mongbwalu to 49 health zones across Ituri, North Kivu, South Kivu, Haut-Uele, and Tshopo. Ituri bears the majority of infections and fatalities, with Bunia, Rwampara, and Mongbwalu among the most severely affected areas. WHO tracked 17,863 contacts by July 30, but only about 75% of them received active follow-up in multiple affected regions. Officials report that many new cases are not linked to known contact chains. Surveillance teams are often discovering cases only after further exposure occurs, complicating containment efforts.
Ongoing conflict and population displacement further hinder surveillance activities. Armed attacks have limited access to affected zones, interrupted response operations, and caused some health teams to cease activities. Movement through mining routes, trade corridors, crowded displacement sites, and across borders keeps many people traveling within these regions. Health facilities face shortages of protective equipment, laboratory access, transportation, and trained personnel. As of July 30, Congo has recorded 151 infections and 44 deaths among healthcare workers. Frontline workers have also ceased operations in some areas due to delayed or insufficient remuneration.
Security and Treatment Shortages Complicate Containment
Ebola transmission occurs through direct contact with blood or bodily fluids of infected or deceased individuals. It does not spread via casual contact like influenza. Transmission risk increases in health clinics lacking strict infection control measures and during burials involving contact with infected bodies. Over 60% of recent fatalities happened outside treatment centers, further complicating safe burial practices and contact tracing efforts. To address this, Congo’s health authorities, WHO, and Africa CDC have expanded laboratory capacity, treatment facilities, community outreach, and border surveillance. Nevertheless, these efforts still lag behind the rapid growth of new cases.
Uganda declared the end of its linked outbreak on July 28 after 42 days without new cases. The single case identified was successfully treated in France, with no secondary transmission. Congo, however, remains the epicenter of ongoing transmission, with a confirmed case fatality rate of approximately 45% in early August. The outbreak’s acceleration is driven by delayed detection, incomplete contact tracing, and insecurity limiting access to affected areas. The absence of approved vaccines and treatments for Bundibugyo virus prevents the application of containment measures that proved effective during previous Zaire Ebola outbreaks. These combined factors contribute to the unusually rapid surge in cases.